Effects of simvastatin and ezetimibe on interleukin-6 and high-sensitivity C-reactive protein

Identical LDL-cholesterol lowering but non-identical effects on NF-κB activity: High dose simvastatin vs combination therapy with ezetimibe

(2012) Gottfried Rudofsky et al.   ATHEROSCLEROSIS

Synergistic effect of simvastatin and ezetimibe on lipid and pro-inflammatory profiles in pre-diabetic subjects

(2012) Ana-Lucia A Kater et al.   Diabetology & Metabolic Syndrome

A pilot study of the short-term use of simvastatin in sickle cell disease: effects on markers of vascular dysfunction

(2011) Carolyn Hoppe et al.   BRITISH JOURNAL OF HAEMATOLOGY

The Effects of Statin Monotherapy and Low-Dose Statin/Ezetimibe on Lipoprotein-Associated Phospholipase A2

(2011) Sang-Hak Lee et al.   CLINICAL CARDIOLOGY

Pleiotropic effects of ezetimibe/simvastatin vs. high dose simvastatin

(2011) Antonio Eduardo P. Pesaro et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Effects of Ezetimibe on Remnant-Like Particle Cholesterol, Lipoprotein (a), and Oxidized Low-Density Lipoprotein in Patients with Dyslipidemia

(2011) Tsuyoshi Nozue et al.   Journal of Atherosclerosis and Thrombosis

The Effect of Ezetimibe and Simvastatin on Monocyte Cytokine Release in Patients With Isolated Hypercholesterolemia

(2011) Robert Krysiak et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Ezetimibe Combined With Simvastatin Compared With Simvastatin Alone Results in a Greater Suppression of Oxidative Stress and Enhanced Fibrinolysis in Patients After Acute Coronary Events

(2011) Anetta Undas et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20 536 patients in the Heart Protection Study

(2011) Heart Protection Study Collaborative Group   LANCET

Ezetimibe alone or in combination with simvastatin increases small dense low-density lipoproteins in healthy men: a randomized trial

(2010) K. Berneis et al.   EUROPEAN HEART JOURNAL

A Randomised Placebo-controlled Double-blind Trial to Evaluate Lipid-lowering Pharmacotherapy on Proteolysis and Inflammation in Abdominal Aortic Aneurysms

(2010) J.A. Dawson et al.   EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY

Inflammation Markers are Associated with Cardiovascular Diseases Risk in Adolescents: The Young Hearts Project 2000

(2010) Nienke J. Wijnstok et al.   JOURNAL OF ADOLESCENT HEALTH

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

(2010) The Emerging Risk Factors Collaboration   LANCET

Interleukin-18 levels are associated with low-density lipoproteins size

(2009) K. Berneis et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial

(2009) Paul M Ridker et al.   LANCET

Pooled Analyses of Effects on C-Reactive Protein and Low Density Lipoprotein Cholesterol in Placebo-Controlled Trials of Ezetimibe Monotherapy or Ezetimibe Added to Baseline Statin Therapy

(2008) Thomas A. Pearson et al.   AMERICAN JOURNAL OF CARDIOLOGY

Effects of ezetimibe and/or simvastatin on LDL receptor protein expression and on LDL receptor and HMG-CoA reductase gene expression: A randomized trial in healthy men

(2007) Ioanna Gouni-Berthold et al.   ATHEROSCLEROSIS

Short-term treatment with ezetimibe, simvastatin or their combination does not alter circulating adiponectin, resistin or leptin levels in healthy men

(2007) Ioanna Gouni-Berthold et al.   CLINICAL ENDOCRINOLOGY